Who Supplies Pioglitazone? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Pioglitazone exports, with 115+ registered manufacturers shipping to buyers across 70+ countries — yet a handful of companies dominate the shipments. AUROBINDO PHARMA LTD holds the largest share at 17.6% (export value: $6.5M). Close behind, AUROBINDO PHARMA LIMITED (8.9%, $3.3M). MACLEODS PHARMACEUTICALS LTD (6.1%, $2.3M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Pioglitazone? Top Manufacturers & Their Buyers
Flow of Pioglitazone from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Pioglitazone Supplier Network — Key Market Intelligence
The Pioglitazone export market from India is led by AUROBINDO PHARMA LTD, which alone commands a 17.6% share, shipping $6.5M worth of product across 547 shipments. The second-largest exporter, AUROBINDO PHARMA LIMITED, contributes $3.3M (8.9%) to the overall market. Combined, the top two suppliers alone account for 26.5% of all Pioglitazone exports, indicating a relatively concentrated supply base.
Across all 115 tracked manufacturers, the total Pioglitazone export value stands at $37.3M from 2.7K shipments. The market average shipment value is $13.9K. The single largest buyer relationship in terms of trade value is RISING PHARMA HOLDINGS, INC. ,, receiving $2.2M worth of product.
The combined buyer network spans 19 named purchasing companies, including RISING PHARMA HOLDINGS, INC. ,, AUROLOGISTICS LLC(AUROBINDO PHARMA, AUROLOGISTICS LLC AUROBINDO PHARM, AUROLOGISTICS LLC, NORTHSTAR DISTRIBUTION CENTER 8912 and 14 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1AUROBINDO PHARMA LTD
AUROBINDO PHARMA LTD is the first-largest Pioglitazone exporter from India, with a market share of 17.6% and a total export value of $6.5M across 547 shipments. Their average shipment value of $12.0K is below the market average of $13.9K, reflecting a high-volume, competitive pricing strategy.
AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• RISING PHARMA HOLDINGS, INC. , — $2.2M across 188 shipments (34.3% of this supplier's total exports)
• AUROLOGISTICS LLC(AUROBINDO PHARMA — $1.9M across 160 shipments (29.2% of this supplier's total exports)
• RISING PHARMA HOLDINGS, INC. , — $1.4M across 115 shipments (21.0% of this supplier's total exports)
• AUROLOGISTICS LLC AUROBINDO PHARM — $720.7K across 60 shipments (11.0% of this supplier's total exports)
• RISING PHARMA HOLDINGS, INC. , — $291.3K across 24 shipments (4.4% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (547 shipments) at a per-shipment value of $12.0K, indicating a broad distribution network with many smaller, regular orders.
2AUROBINDO PHARMA LIMITED
AUROBINDO PHARMA LIMITED is the second-largest Pioglitazone exporter from India, with a market share of 8.9% and a total export value of $3.3M across 161 shipments. Their average shipment value of $20.7K is above the market average of $13.9K, suggesting premium or bulk contract pricing.
AUROBINDO PHARMA LIMITED serves 5 named buyers in our database. RISING PHARMA HOLDINGS, INC. , is the dominant customer, accounting for 51.7% of this supplier's tracked business. Top customers include:
• RISING PHARMA HOLDINGS, INC. , — $1.7M across 83 shipments (51.7% of this supplier's total exports)
• AUROLOGISTICS LLC AUROBINDO PHARM — $666.8K across 32 shipments (20.1% of this supplier's total exports)
• AUROLOGISTICS LLC — $447.0K across 22 shipments (13.4% of this supplier's total exports)
• RISING PHARMA HOLDINGS, INC. , — $286.2K across 14 shipments (8.6% of this supplier's total exports)
• AUROLOGISTICS LLC(AUROBINDO PHARMA — $205.0K across 10 shipments (6.2% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LIMITED's per-shipment value of $20.7K is 48% above the market average of $13.9K, consistent with large-order contracts or value-added formulations.
3MACLEODS PHARMACEUTICALS LTD
MACLEODS PHARMACEUTICALS LTD is the third-largest Pioglitazone exporter from India, with a market share of 6.1% and a total export value of $2.3M across 311 shipments. Their average shipment value of $7.3K is below the market average of $13.9K, reflecting a high-volume, competitive pricing strategy.
MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• NORTHSTAR DISTRIBUTION CENTER 8912 — $930.6K across 128 shipments (41.1% of this supplier's total exports)
• MACLEODS PHARMA USA,INC — $687.3K across 95 shipments (30.4% of this supplier's total exports)
• MACLEODS PHARMA USA,INC — $249.6K across 34 shipments (11.0% of this supplier's total exports)
• MACLEODS PHARMA USA,INC — $236.4K across 33 shipments (10.5% of this supplier's total exports)
• MACLEODS PHARMA USA,INC — $157.7K across 22 shipments (7.0% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LTD operates with high shipment frequency (311 shipments) at a per-shipment value of $7.3K, indicating a broad distribution network with many smaller, regular orders.
4AJANTA PHARMA LIMITED
AJANTA PHARMA LIMITED is the fourth-largest Pioglitazone exporter from India, with a market share of 4.5% and a total export value of $1.7M across 36 shipments. Their average shipment value of $46.7K is above the market average of $13.9K, suggesting premium or bulk contract pricing.
AJANTA PHARMA LIMITED serves 5 named buyers in our database. AJANTA PHARMA PHILIPPINES INC is the dominant customer, accounting for 58.6% of this supplier's tracked business. Top customers include:
• AJANTA PHARMA PHILIPPINES INC — $984.5K across 21 shipments (58.6% of this supplier's total exports)
• HAWKARY PHARMACEUITC — $382.6K across 8 shipments (22.8% of this supplier's total exports)
• Al-Thuraya Scientifi — $181.7K across 4 shipments (10.8% of this supplier's total exports)
• HAWKARY PHARMACEUITC — $85.3K across 2 shipments (5.1% of this supplier's total exports)
• SHAMS AL-THURAYA CO — $46.1K across 1 shipments (2.7% of this supplier's total exports)
Key Insight: AJANTA PHARMA LIMITED's per-shipment value of $46.7K is 235% above the market average of $13.9K, consistent with large-order contracts or value-added formulations.
5INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the fifth-largest Pioglitazone exporter from India, with a market share of 4.5% and a total export value of $1.7M across 473 shipments. Their average shipment value of $3.5K is below the market average of $13.9K, reflecting a high-volume, competitive pricing strategy.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER — $639.9K across 181 shipments (38.2% of this supplier's total exports)
• NOVATIN LIMITED — $391.6K across 111 shipments (23.4% of this supplier's total exports)
• ACCORD UK — $217.2K across 61 shipments (13.0% of this supplier's total exports)
• S C F SRL — $216.1K across 61 shipments (12.9% of this supplier's total exports)
• NOVATIN LTD CONSIGNE — $211.7K across 60 shipments (12.6% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (473 shipments) at a per-shipment value of $3.5K, indicating a broad distribution network with many smaller, regular orders.
6MICRO LABS LIMITED
MICRO LABS LIMITED is the fifth-largest Pioglitazone exporter from India, with a market share of 2.7% and a total export value of $1.0M across 98 shipments. Their average shipment value of $10.4K is below the market average of $13.9K, reflecting a high-volume, competitive pricing strategy.
MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• BROWN AND BURK PHILIPPINES INC — $396.8K across 38 shipments (38.8% of this supplier's total exports)
• OEP PHILIPPINES INC — $297.7K across 29 shipments (29.1% of this supplier's total exports)
• SUED & FARGESA — $145.0K across 14 shipments (14.2% of this supplier's total exports)
• MICRO NOVA PHARMACEU — $137.9K across 13 shipments (13.5% of this supplier's total exports)
• UNICHEM 2005 COMPANY — $45.6K across 4 shipments (4.5% of this supplier's total exports)
Key Insight: MICRO LABS LIMITED operates with high shipment frequency (98 shipments) at a per-shipment value of $10.4K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Pioglitazone Flows
Once Pioglitazone leaves the manufacturing plants of companies like AUROBINDO PHARMA LTD and AUROBINDO PHARMA LIMITED, it travels to 5 destination markets with a combined import value of $37.3M. United States absorbs the largest share at 60.5% ($22.6M), followed by Philippines (7.8%) and Italy (3.2%).
In United States — the top destination — named importers include RISING PHARMA HOLDINGS, INC. ,., RISING PHARMA HOLDINGS, INC., AUROLOGISTICS LLC (AUROBINDO PHARMA. In Philippines, key buyers are AJANTA PHARMA PHILIPPINES INC, AMBICA INTERNATIONAL CORPORATION, BROWN AND BURK PHILIPPINES INC.
This geographic spread reflects Pioglitazone's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Pioglitazone Go? Top Importing Countries & Their Buyers
Trade flow of Pioglitazone exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Pioglitazone imports from India, with a total trade value of $22.6M across 829 shipments — representing a 60.5% share of all Pioglitazone exports. The average shipment value of $27.2K is above the global average of $13.9K, indicating high-value procurement contracts or branded formulations. This market is served by 13 tracked buyers.
Named Pioglitazone importers in United States: RISING PHARMA HOLDINGS, INC. ,. is the largest buyer, accounting for 12.5% ($2.8M) of this market's total imports.
• RISING PHARMA HOLDINGS, INC. ,. — $2.8M (12.5% of United States's total)
• RISING PHARMA HOLDINGS, INC. — $2.6M (11.6% of United States's total)
• AUROLOGISTICS LLC (AUROBINDO PHARMA — $2.4M (10.8% of United States's total)
Key Insight: United States's per-shipment average of $27.2K (95% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Pioglitazone imports from India.
2Philippines
Philippines ranks as the second-largest destination for Pioglitazone imports from India, with a total trade value of $2.9M across 87 shipments — representing a 7.8% share of all Pioglitazone exports. The average shipment value of $33.3K is above the global average of $13.9K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Pioglitazone importers in Philippines: AJANTA PHARMA PHILIPPINES INC is the largest buyer, accounting for 34.0% ($984.5K) of this market's total imports.
• AJANTA PHARMA PHILIPPINES INC — $984.5K (34.0% of Philippines's total)
• AMBICA INTERNATIONAL CORPORATION — $601.5K (20.8% of Philippines's total)
• BROWN AND BURK PHILIPPINES INC — $427.9K (14.8% of Philippines's total)
Key Insight: Philippines's per-shipment average of $33.3K (139% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Philippines is a key market for Pioglitazone imports from India.
3Italy
Italy ranks as the third-largest destination for Pioglitazone imports from India, with a total trade value of $1.2M across 0 shipments — representing a 3.2% share of all Pioglitazone exports. The average shipment value of $1.2M is above the global average of $13.9K, indicating high-value procurement contracts or branded formulations.
Key Insight: Italy's per-shipment average of $1.2M (8526% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Italy is a key market for Pioglitazone imports from India.
4Jamaica
Jamaica ranks as the fourth-largest destination for Pioglitazone imports from India, with a total trade value of $1.1M across 0 shipments — representing a 3.0% share of all Pioglitazone exports. The average shipment value of $1.1M is above the global average of $13.9K, indicating high-value procurement contracts or branded formulations.
Key Insight: Jamaica's per-shipment average of $1.1M (7918% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Jamaica is a key market for Pioglitazone imports from India.
5Croatia
Croatia ranks as the fifth-largest destination for Pioglitazone imports from India, with a total trade value of $1.1M across 0 shipments — representing a 2.8% share of all Pioglitazone exports. The average shipment value of $1.1M is above the global average of $13.9K, indicating high-value procurement contracts or branded formulations.
Key Insight: Croatia's per-shipment average of $1.1M (7487% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Croatia is a key market for Pioglitazone imports from India.
People Also Ask — Pioglitazone Supplier & Trade Network
Who are the top suppliers of Pioglitazone from India?+
Which companies buy Pioglitazone from Indian manufacturers?+
Where does Pioglitazone exported from India go?+
What is the market share of the top Pioglitazone supplier from India?+
What is the average shipment value for Pioglitazone exports from India?+
Is Pioglitazone manufactured in India and exported globally?+
Which country imports the most Pioglitazone from India?+
Who are the buyers of Pioglitazone in Philippines?+
How concentrated is the Pioglitazone supplier market in India?+
How do I find verified buyers for Pioglitazone in specific countries?+
Pioglitazone Trade Network — Key Takeaways
- 1AUROBINDO PHARMA LTD is India's dominant Pioglitazone exporter with a 17.6% market share and $6.5M in total exports — making it the single most important sourcing entity in this market.
- 2The top 115 suppliers collectively account for 44.3% of all tracked Pioglitazone exports, with a combined trade value of $37.3M.
- 3United States is the largest destination market, absorbing 60.5% of India's Pioglitazone exports ($22.6M). Philippines (7.8%) and Italy (3.2%) follow.
- 4With 2.7K total shipments averaging $13.9K each, the Pioglitazone export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include RISING PHARMA HOLDINGS, INC. ,, AUROLOGISTICS LLC(AUROBINDO PHARMA, RISING PHARMA HOLDINGS, INC. ,, AUROLOGISTICS LLC AUROBINDO PHARM — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 70 countries
Network value: $37.3M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Pioglitazone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Pioglitazone.
- 2.Flow Mapping: 115 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,674 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 70 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,674 Verified Shipments
115 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists